1. Home
  2. BCAX vs NPB Comparison

BCAX vs NPB Comparison

Compare BCAX & NPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAX
  • NPB
  • Stock Information
  • Founded
  • BCAX 2018
  • NPB 1999
  • Country
  • BCAX United States
  • NPB United States
  • Employees
  • BCAX N/A
  • NPB N/A
  • Industry
  • BCAX
  • NPB
  • Sector
  • BCAX
  • NPB
  • Exchange
  • BCAX NYSE
  • NPB NYSE
  • Market Cap
  • BCAX 541.0M
  • NPB 449.1M
  • IPO Year
  • BCAX 2024
  • NPB 2025
  • Fundamental
  • Price
  • BCAX $10.53
  • NPB $14.51
  • Analyst Decision
  • BCAX Strong Buy
  • NPB Buy
  • Analyst Count
  • BCAX 7
  • NPB 2
  • Target Price
  • BCAX $29.17
  • NPB $17.75
  • AVG Volume (30 Days)
  • BCAX 329.8K
  • NPB 153.3K
  • Earning Date
  • BCAX 08-16-2025
  • NPB 07-22-2025
  • Dividend Yield
  • BCAX N/A
  • NPB 0.69%
  • EPS Growth
  • BCAX N/A
  • NPB N/A
  • EPS
  • BCAX N/A
  • NPB 2.02
  • Revenue
  • BCAX N/A
  • NPB $204,712,000.00
  • Revenue This Year
  • BCAX N/A
  • NPB $27.37
  • Revenue Next Year
  • BCAX N/A
  • NPB $13.48
  • P/E Ratio
  • BCAX N/A
  • NPB $7.18
  • Revenue Growth
  • BCAX N/A
  • NPB N/A
  • 52 Week Low
  • BCAX $7.80
  • NPB $11.43
  • 52 Week High
  • BCAX $28.09
  • NPB $15.50
  • Technical
  • Relative Strength Index (RSI)
  • BCAX N/A
  • NPB N/A
  • Support Level
  • BCAX N/A
  • NPB N/A
  • Resistance Level
  • BCAX N/A
  • NPB N/A
  • Average True Range (ATR)
  • BCAX 0.00
  • NPB 0.00
  • MACD
  • BCAX 0.00
  • NPB 0.00
  • Stochastic Oscillator
  • BCAX 0.00
  • NPB 0.00

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

About NPB NORTHPOINTE BANCSHARES INC

Northpointe Bancshares Inc operates its business through its wholly-owned banking subsidiary, Its lending focus is the origination of residential mortgages throughout the United States. The majority of these loans are sold in the secondary market through a network of investors. The Company has also developed mortgage advance program that provides funding to pre-approved mortgage bankers who originate and sell individual conforming and non-qualified loan products in the secondary market. The Company continues to service loans that were originated and sold to investors as well as loans held in its portfolio which were originated and selectively held in portfolio.

Share on Social Networks: